Share

    


In This Section

Home / News & Media / Coronavirus Response

Coronavirus Response

When the coronavirus disease began to spread widely in the United States, ACCC members on the frontlines of the pandemic came together as a community to share their perspective and lessons learned by participating in ACCC webcasts, mini-podcasts, and blog posts. The educational resources included in this COVID-19 Resource Center represent the expertise, dedication, and generosity of ACCC members across the nation who have been deeply involved in caring for patients and establishing protocols for virus response since March 2020.

On January 7, 2021, U.S. Department of Health and Human Services (HHS) Secretary Alex Azar signed an extension of the COVID-19 public health emergency (PHE) designation until April 21, 2021. ACCC resources from the pandemic's acute phase and pre-vaccination phase are accessible to help cancer programs and practices that still face many pressing issues related to COVID-19.

COVID-19 Resources 

HHS-60x60combatCOVID.hhs.gov provides important information and links to access the most current treatment guidelines and inpatient and outpatient clinical trials.

The LUNGevity Foundation's COVID-19 Vaccine FAQs provides information from trusted sources (in English and Spanish) for informed patient-provider conversations about getting a COVID-19 vaccine.

AMCCBS Virtual 

In the wake of COVID-19, seismic changes have pushed cancer care providers to continue to prove their resiliency and ability to quickly adapt to change. View on-demand sessions from the ACCC 47th Annual Meeting & Cancer Center Business Summit to hear real-world examples from institutions that have used the opportunity created by this pandemic to forge a new path forward.

  • Cancer Care in the COVID-19 Era
  • Virtual Solutions: Oncology Telemedicine for Rural Communities
  • Cancer Care During the Pandemic: The Good, the Bad, and the Ugly from the Patient Perspective
  • Experience of a Large Cancer Center Adjusting to COVID-19, and more!

Explore the agenda and the opportunity to register at reduced rates.

Financial Resources 

The ACCC Financial Advocacy Network developed the COVID-19 Financial Advocacy Resources hub to help cancer programs and practices to stay informed on rapidly changing updates to financial assistance programs and insurance coverage in response to the public health emergency. This resource will be reviewed and updated weekly.

Telehealth 

Adoption & Expansion of Telehealth Solutions addresses the immediate and ongoing needs of cancer programs and practices that want to implement, integrate, and expand their telehealth services to optimize patient care during the current public health emergency and beyond. Through this effort, ACCC will help guide members of the multidisciplinary team in the areas of rapid response, policy rules and regulations, team-based telehealth delivery, technology needs, and actionable blueprints to build new telehealth solutions.

COVID-19 Webcasts 

  • An expert panel of past ACCC Presidents will share their perspectives on changes to clinical research during the pandemic.

  • COVID-19 has impacted how providers are dispensing multiple myeloma medications and providing care to patients during the pandemic. Learn how to identify those effects to help mitigate them and implement strategies to improve telehealth medicine during the pandemic.

  • Join Charles Saunders, MD, Chief Executive Officer, and Jennifer Webster, MS, Vice President of Analytics, IntegraConnect, as they present an overview of the current landscape of patient levels and services at cancer programs. (July 10, 2020)

  • Teri Bedard, BA, RT(R)(T), CPC, Executive Director, Client & Corporate Resources, Revenue Cycle Coding Strategies, highlights what your cancer program needs to know by discussing the changes to telehealth services, supervision, provider-based designations, and coding for services. (July 10, 2020)

  • Join Raju K. Vaddepally, MD, Yuma Regional Medical Center Cancer Center, to discuss strategies for sustaining a robust clinical trials program in uncertain times and how to increase the relevance of research to vulnerable and underserved patients. (June 26, 2020)

Presentation 

Covid Poster Presentation

COVID-19 Podcasts 

 

  • [MINI-PODCAST] Ep 77: Virtual Integrative Services
    Mar 7, 2022

    Hear how a virtual integrative format can enable cancer programs to adapt touch modalities to self-interventions, leverage opportunities for research, and overcome social and economic barriers. 


     

  • [MINI-PODCAST] Ep 64: A Summer of Disconnect for Cancer Professionals
    Jul 20, 2021
    In this episode, we focus on the mental and emotional toll that COVID-19 continues to have on cancer care professionals—while much of the public experiences a “summer of joy” due to rising vaccinations.
  • [MINI-PODCAST] Ep 58: Impact of COVID-19 on Revenue Optimization
    May 18, 2021

    Explores the impact of the COVID-19 pandemic on the financial health of cancer programs and practices across the country, from lower patient volume and screening interventions and decreased revenue streams.

  • [PODCAST] Ep 57: COVID-19 Challenges: Managing Patients with CLL
    May 11, 2021
    A physician assistant shares the challenges related to COVID-19, the vaccine, and how his program is adapting to keep diagnosed patients with chronic lymphocytic leukemia (CLL) safe.
  • [PODCAST] Ep 56: What Comes Next for Telehealth?
    Apr 27, 2021

    We'll discuss the telehealth regulatory and policy changes enacted during the COVID-19 pandemic, what may change in 2021, and what’s likely to remain the same regarding the reimbursement of remote care. 

  • [PODCAST] Ep 53: Telehealth & Genetics During COVID-19
    Feb 23, 2021

    Learn how genetic healthcare services have adapted to virtual care delivery, and what challenges face its widespread use after the COVID-19 pandemic is over.

  • [MINI-PODCAST] Ep 46: Supporting Caregivers During COVID-19
    Dec 22, 2020

    Learn how the role of caregivers has changed during the pandemic, and how the cancer team can provide caregivers with guidance on taking care of patients with cancer.

ASCO COVID-19 REGISTRY  

ASCO-Registry-191x30The ASCO Survey on COVID-19 in Oncology Registry (ASCO Registry) is aimed to help ASCO examine the evidence on the effect of COVID-19 on patients with cancer. The ASCO Registry collects baseline and longitudinal data on patients with cancer and COVID-19 and plans to deliver periodic reports with key findings that can influence future care. The greater diversity and number of patients the Registry represents, the more we can learn from this unique experience in cancer care. Join the Registry.

 

Publications 

2020 Trending Now ImageTrending Now in Cancer Care
Rather than fielding its annual Trending Now in Cancer Care survey while cancer programs were experiencing unprecedented challenges due to the extended public health emergency, ACCC facilitated conversations with its members to capture the lived experiences of the most pertinent issues impacting oncology practice and care delivery.
 
2020 Trending Now in Cancer Care Fast Facts 2Fast Facts Infographic
This Fast Facts infographic details key findings on how COVID-19 impacted access to telehealth, clinical research protocols, innovative staff recognition, moving the needle on health equity, virtual financial navigation, and more!
 
Telehealth At Its Best ThumbnailTelehealth at Its Best: Transitioning a Comprehensive Psychosocial Program to a Virtual Format
Due to the COVID-19 pandemic and its associated risks for patients with cancer, all Life with Cancer programming was cancelled on Mar. 12, 2020. Staff, struggling with their own anxiety over personal safety, quickly went into action on how best to continue to meet the psychological and educational needs of patients and families.
 
The Road To Recovery ThumbnailCancer & COVID-19: The Road to Recovery (ASCO Publication)
Recommendations for Post-Pandemic Cancer Care and Research
  • COVID-19 and Patients Receiving Anticancer Immunotherapy
    COVID-19 and Patients Receiving Anticancer Immunotherapy
    Nov 20, 2020

    SARS-CoV-2 and the resulting respiratory tract infection COVID-19 has upended our society and forcefully changed the way we care for patients. Since the emergence of the virus in early 2020, there have been questions surrounding the risk posed to patients with a cancer diagnosis and the safety of anticancer therapies. 

For more information on this project, please contact the ACCC Provider Education department.